Page 3 - Isotope Program News Today

Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory for producing alpha-emitting medical radioisotopes intended to target and overpower diseased tissue while sparing the healthy tissue around it.

Technicians John Dyer and T. Dyer use a manipulator arm in a shielded cave in ORNL's Radiochemical Engineering Development Center to separate...

LOS ALAMOS, N.M., March 10, 2021—Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory...

Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Enters into Long-Term Supply Agreement with the National Isotope Development Center of the U.S. Department of Energy Isotope Program ?? -GEN isotope generator, which enables a nimble supply of therapeutic radioisotopes with the power of alpha-particle therapy for cancer CORALVILLE, IA / ACCESSWIRE / February 18, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing pr...

Award winning Imaging Technology News (ITN) reaches more than 34,000 radiology, radiation oncology, women's health and nuclear medicine professionals.

Reaping FRIB’s isotopes to sow new science A new $13 million grant is helping the Facility for Rare Isotope Beams at MSU harvest unused isotopes for a variety of research fields It’s no secret that Michigan State University is a leader in nuclear science. The university boasts the nation’s top-ranked nuclear physics graduate program. It’s also the home to the Facility for Rare Isotope Beams, a U.S. Department of Energy Office of Science, or DOE-SC, user facility that will power cutting...

New Diagnostic Isotope to Enhance Targeted Alpha Therapy for Cancer Team brings a new tool for alpha therapy by developing a paired isotope option for PET scans A multidisciplinary team of researchers have demonstrated production, purification, and potential for the 134Ce/134La in vivo generator as a PET imaging surrogate for 225Ac and 227Th radiotherapeutic agents. December 22, 2020 — Researchers in the DOE Isotope Program have developed an effective radionuclide, cerium-134, as a paired a...

 E-Mail IMAGE: Katherine Shield (from left), Dahlia An, Tyler Bailey at Lawrence Berkeley National Laboratory on Tuesday, November 17, 2020, in Berkeley, Calif. view more  Credit: Marilyn Sargent/Berkeley Lab A promising approach to treating cancer - called targeted alpha-particle therapy or TAT - could better harness the curative power of radiation treatments and lessen the severity of their more debilitating side effects. TAT recruits drugs containing radioactive materials called a...